vorinostat has been researched along with Abscess, Amebic in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Montaño, S | 1 |
| Constantino-Jonapa, LA | 1 |
| Sixto-López, Y | 1 |
| Hernández-Ramírez, VI | 1 |
| Hernández-Ceruelos, A | 1 |
| Romero-Quezada, LC | 1 |
| Ruvalcaba-Ledezma, JC | 1 |
| Talamás-Rohana, P | 1 |
| López-Contreras, L | 1 |
1 other study available for vorinostat and Abscess, Amebic
| Article | Year |
|---|---|
Vorinostat, a possible alternative to metronidazole for the treatment of amebiasis caused by
Topics: Amebiasis; Entamoeba histolytica; Histone Deacetylases; Metronidazole; Molecular Docking Simulation; | 2020 |